- Emerson Electric Co EMR reported first-quarter FY22 net sales growth of 8% year-over-year to $4.47 billion, in line with the consensus of $4.47 billion. Underlying sales were up 8%.
- Adjusted EPS improved 13% Y/Y to $1.05, beating the consensus of $0.99.
- Sales by segments: Measurement & Analytical Instrumentation $735 million (+5.3% Y/Y), Valves, Actuators & Regulators $816 million (+1.2% Y/Y), Industrial Solutions $566 million (+11.4% Y/Y), Systems & Software $688 million (+1.2% Y/Y), Climate Technologies $1.16 billion (+12.8% Y/Y) and Tools & Home Products $508 million (+14.2% Y/Y).
- December trailing three-month underlying orders were up 17%, as demand continued to be strong across all world areas and major end markets.
- The pretax margin was 26.3%, up 1280 bps for the quarter. Adjusted EBITA margin was 19.6%, up by 140 bps.
- Operating cash flow was $523 million (-35% Y/Y), and free cash flow was $407 million (-41% Y/Y); cash flow results reflect higher inventory due to supply chain constraints.
- The company declared a quarterly cash dividend of $0.515 per share, payable March 10, 2022, to stockholders of record on February 11, 2022.
- 2Q22 Outlook: Emerson Electric expects net sales growth of 4% - 6% with underlying sales growth of 6% - 8%. It expects an adjusted EPS of $1.15 - $1.20 versus the consensus of $1.19.
- FY22 Outlook: Emerson Electric expects net sales growth of 6% - 8% (prior expectation 5% - 7%), with underlying sales growth of 7% - 9% (prior 6% - 8%).
- It expects an adjusted EPS of $4.90 - $5.05 (prior $4.82 - $4.97) versus the consensus of $4.91.
- Price Action: EMR shares are trading higher by 0.56% at $93 during the premarket session on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in